Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Stanford, CA
NPI: 1538201405Primary Practice Location
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA
Primary Employer
Stanford Hospital
stanfordhealthcare.org
HQ Phone
Get MD Caroline's Phone Numberphone_androidMobile
Get MD Caroline's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2001 - 2027
University of Montreal
Hematology
1987 - 1989
Laval Univ
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 25 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 21 | 21 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 20 | 31 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 19 | 23 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 18 | 29 |
Authors: Jia Ruan, Daniel Arber, Jason Gotlib, Stephen Galli
Journal: Blood
Publication Date: 2005-06-21
Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML.
Authors: Gabriel Mannis, Abdullah Ladha, Jason Gotlib
Publication Date: 2021-01-25
Authors: Omar Abdel-Wahab, Daniel Pollyea, Peter Greenberg, Michaela Liedtke, James Zehnder, Jason Gotlib, Beverly Mitchell
Journal: Haematologica
Publication Date: 2012-12-14
Lead Sponsor: Steven E. Coutre
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Ibrutinib, DRUG: Cytarabine, DRUG: Idarubicin
Lead Sponsor: Washington University School of Medicine
Collaborators: Genentech, Inc., National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Boston Scientific Corporation, McMaster University, Medtronic - MITG, Ontario Clinical Oncology Group (OCOG), BSN Medical Inc, Mid America Heart Institute, Society of Interventional Radiology Foundation
Intervention / Treatment: DRUG: Recombinant tissue plasminogen activator (rt-PA)